Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Monoclonal Antibody

Anti-Mouse EHF/ESE-3 Monoclonal Antibody (1A145)

Catalog #:   MMK12302 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: ELISA, IHC, WB
Accession: O70273
Overview

Catalog No.

MMK12302

Species reactivity

Mouse

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Immunogen

E. coli - derived recombinant Mouse EHF / ESE-3 (Ile2-Asn127).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:2000-1:8000

Target

ETS domain-containing transcription factor,ESE-3,ESE3B,Epithelium-specific Ets transcription factor 3,ESE3,EHF,ETS homologous factor,hEHF,ESEJ,

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

O70273

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

1A145

Data Image
References

Differences in pharmacological migraine treatment across different levels of clinical headache care - a cross-sectional study., PMID:40229741

Atypical presentation of a common condition., PMID:39973525

In Vitro Evaluation of the Safety and Efficacy of Cibisatamab Using Adult Stem Cell-Derived Organoids and Colorectal Cancer Spheroids., PMID:39858076

Allergenicity evaluation of an extensively hydrolyzed infant formula based on cow milk protein., PMID:39431858

Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study., PMID:39246225

Safety and Patient-Reported outcomes of atezolizumab plus chemotherapy with or without bevacizumab in stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies (GFPC 06-2018 study)., PMID:38830303

Future targets for migraine treatment beyond CGRP., PMID:37370051

Extensively Hydrolyzed Formula Improves Allergic Symptoms in the Short Term in Infants with Suspected Cow's Milk Protein Allergy., PMID:37049517

Effect of switching to erenumab in non-responders to a CGRP ligand antibody treatment in migraine: A real-world cohort study., PMID:37034092

Prolactin and oxytocin: potential targets for migraine treatment., PMID:36967387

Tolerance Induction in Cow's Milk Allergic Children by Heated Cow's Milk Protein: The iAGE Follow-Up Study., PMID:36904179

The sense of stopping migraine prophylaxis., PMID:36792981

Extensively Hydrolyzed Hypoallergenic Infant Formula with Retained T Cell Reactivity., PMID:36615769

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update., PMID:35690723

Maternal and Newborn Thyroid Hormone, and the Association With Polychlorinated Biphenyls (PCBs) Burden: The EHF (Environmental Health Fund) Birth Cohort., PMID:34589452

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials., PMID:34301173

1st Post-European Headache Federation Meeting: a review of the latest developments presented at the 2020 European Headache Federation Congress., PMID:34180043

Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment - real world outcomes., PMID:33421995

Effect of calcitonin gene-related peptide (-receptor) antibodies in chronic cluster headache: Results from a retrospective case series support individual treatment attempts., PMID:32806953

European Headache Federation recommendations for neurologists managing giant cell arteritis., PMID:32183689

Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003., PMID:31309259

A new score to predict allergic march in patients with IgE-mediated cow milk allergy., PMID:31018894

CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?, PMID:30866804

A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway., PMID:30782177

Preclinical Brown Norway Rat Models for the Assessment of Infant Formulas in the Prevention and Treatment of Cow's Milk Allergy., PMID:30759437

MET activation confers resistance to cetuximab, and prevents HER2 and HER3 upregulation in head and neck cancer., PMID:30694565

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention., PMID:30651064

Early onset of efficacy with erenumab in patients with episodic and chronic migraine., PMID:30276500

Migraine and cluster headache - the common link., PMID:30242519

Oral Immunotherapy Using Partially Hydrolyzed Formula for Cow's Milk Protein Allergy: A Randomized, Controlled Trial., PMID:30134240

Immunogenicity of a Candidate Ebola Hemorrhagic Fever Vaccine in Mice Based on Controlled In Vitro Expression of Ebolavirus Glycoprotein., PMID:30095362

PACAP38 and PAC1 receptor blockade: a new target for headache?, PMID:30088106

Calcitonin gene-related peptide receptor as a novel target for the management of people with episodic migraine: current evidence and safety profile of erenumab., PMID:29263689

Triptans and CGRP blockade - impact on the cranial vasculature., PMID:29019093

Blocking CGRP in migraine patients - a review of pros and cons., PMID:28948500

The ongoing evolution of antibody-based treatments for Ebola virus infection., PMID:28357917

Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis., PMID:28262670

Consensus statement on diagnosis, treatment and follow-up of cow's milk protein allergy among infants and children in Turkey., PMID:27922230

Intra- and inter-laboratory validation of an innovative huFcεRIα-RBL-2H3 degranulation assay for in vitro allergenicity assessment of whey hydrolysates., PMID:26921666

[Evaluation of Efficacy and Safety of Longterm Feeding with Amino Acid-Based Formula in Infants with Cow’s Milk Protein Allergy: Results of the Open-Label Prospective Controlled Post-Registration Trial]., PMID:29298008

The Transcription Factor Ehf Is Involved in TGF-β-Induced Suppression of FcεRI and c-Kit Expression and FcεRI-Mediated Activation in Mast Cells., PMID:26297757

Pharmacotherapy of Ebola hemorrhagic fever: a brief review of current status and future perspectives., PMID:25694097

The role of the carbohydrate recognition domain of placental protein 13 (PP13) in pregnancy evaluated with recombinant PP13 and the DelT221 PP13 variant., PMID:25079598

Pneumococcal polysaccharide abrogates conjugate-induced germinal center reaction and depletes antibody secreting cell pool, causing hyporesponsiveness., PMID:24069152

The SRC family tyrosine kinase HCK and the ETS family transcription factors SPIB and EHF regulate transcytosis across a human follicle-associated epithelium model., PMID:23439650

Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever., PMID:22558378

Dead or alive: animal sampling during Ebola hemorrhagic fever outbreaks in humans., PMID:22558004

Subarachnoid hemorrhage associated with epidemic hemorrhagic fever: a rare case report., PMID:22135608

Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus., PMID:21666792

The effect of a partially hydrolysed formula based on rice protein in the treatment of infants with cow's milk protein allergy., PMID:20337976

Datasheet
$ 196
Product specifications
50 μg 196 100 μg 313

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Mouse EHF/ESE-3 Monoclonal Antibody (1A145) [MMK12302]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only